Cell Signaling Technology

PINK1 (D8G3) Rabbit Monoclonal Antibody

#6946 · $152

100
Citing papers
8.6k
Combined citations
Supplier page Find this product

Research areas

Autophagy in Disease and Therapy25Cell death mechanisms and regulation10PI3K/AKT/mTOR signaling in cancer9Mitochondrial Function and Pathology8Cancer-related Molecular Pathways7MicroRNA in disease regulation6Parkinson's Disease Mechanisms and Treatments6DNA Repair Mechanisms6

Papers citing this product

1
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
Journal of Clinical Investigation·2005·836 cit.·DOI
2
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Nature·2018·706 cit.·DOI
3
Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer
BMC Cancer·2014·296 cit.·DOI
4
TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Molecular Cancer Research·2008·234 cit.·DOI
5
Inhibition of StearoylCoA Desaturase-1 Inactivates Acetyl-CoA Carboxylase and Impairs Proliferation in Cancer Cells: Role of AMPK
PLoS ONE·2009·200 cit.·DOI
6
Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
PLoS Pathogens·2009·199 cit.·DOI
7
PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1–Parkin-mediated mitophagy
Cell Research·2018·179 cit.·DOI
8
NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions
PLoS ONE·2015·179 cit.·DOI
9
A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota
Microbiome·2021·160 cit.·DOI
10
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
Nature Communications·2023·156 cit.·DOI